The Anticancer Journey of Liquiritin: Insights into Its Mechanisms and Therapeutic Prospects

Liquiritin (LIQ), a bioactive flavonoid from Glycyrrhiza species, has shown significant potential in cancer therapy. LIQ exhibits potent inhibitory effects on various cancer cell types, including breast, lung, liver, and colon cancers, while demonstrating low toxicity towards healthy cells. Its anticancer mechanisms include inducing cell cycle arrest, promoting apoptosis, and modulating inflammation-related pathways. Additionally, LIQ impedes angiogenesis and enhances the efficacy of conventional chemotherapies through sensitization and synergistic effects with other natural compounds and targeted therapies. These multifaceted actions highlight LIQ as a promising candidate for further development as an anticancer agent. This abstract provides an overview of LIQ's chemistry, biological effects, and underlying mechanisms.

Authors

Institutions

Publication Details

Journal
Current Medicinal Chemistry
Published
2024-08-20
DOI
https://doi.org/10.2174/0109298673315699240805111122
Citations
9
Primary Topic
Pharmacological Effects of Natural Compounds
Type
article
Field-Weighted Citation Impact
4.20
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Anticancer Journey of Liquiritin: Insights into Its Mechanisms and Therapeutic Prospects

Riya Thapa, Sami I. Alzarea, Sachin Kumar Singh, Kamal Dua et al.
9 citations
Current Medicinal Chemistry
Pharmacological Effects of Natural Compounds
4.20
article

The Anticancer Journey of Liquiritin: Insights into Its Mechanisms and Therapeutic Prospects

Riya Thapa, Sami I. Alzarea, Sachin Kumar Singh, Kamal Dua, Ehssan Moglad, Waleed Hassan Almalki, Asif Ahmad Bhat, Neetu Agrawal, Imran Kazmi, Sanjay Sharma, Muhammad Afzal, Ali Haider, Gaurav Gupta
article en
9 citations

Abstract

Liquiritin (LIQ), a bioactive flavonoid from Glycyrrhiza species, has shown significant potential in cancer therapy. LIQ exhibits potent inhibitory effects on various cancer cell types, including breast, lung, liver, and colon cancers, while demonstrating low toxicity towards healthy cells. Its anticancer mechanisms include inducing cell cycle arrest, promoting apoptosis, and modulating inflammation-related pathways. Additionally, LIQ impedes angiogenesis and enhances the efficacy of conventional chemotherapies through sensitization and synergistic effects with other natural compounds and targeted therapies. These multifaceted actions highlight LIQ as a promising candidate for further development as an anticancer agent. This abstract provides an overview of LIQ's chemistry, biological effects, and underlying mechanisms.

Current Medicinal ChemistryVol. 32(28)
Lovely Professional University (IN), University of Technology Sydney (AU), Prince Sattam Bin Abdulaziz University (SA), Ajman University (AE), King Abdulaziz University (SA), Umm al-Qura University (SA), Jouf University (SA), Narsee Monjee Institute of Management Studies (IN), Batterjee Medical College, Graphic Era University (IN), GLA University (IN), Saveetha University (IN), Gyan Vihar University (IN)
Openalex Percentile: Top 6%
Pharmacological Effects of Natural Compounds
4.20
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.